Provided by Tiger Trade Technology Pte. Ltd.

PolyPid Ltd.

3.93
-0.0200-0.51%
Volume:22.95K
Turnover:90.62K
Market Cap:65.37M
PE:-1.50
High:3.99
Open:3.95
Low:3.90
Close:3.95
52wk High:4.07
52wk Low:2.30
Shares:16.63M
Float Shares:10.06M
Volume Ratio:0.38
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.6165
EPS(LYR):-4.9083
ROE:-390.53%
ROA:-87.91%
PB:4.25
PE(LYR):-0.80

Loading ...

Press Release: PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors

Dow Jones
·
Dec 16

BRIEF-Polypid Announces Positive FDA Pre-NDA Meeting Minutes

Reuters
·
Dec 03

PolyPid Ltd - FDA Agreed to a Rolling Nda Review, Allowing PolyPid to Submit First Completed Sections in Early 2026

THOMSON REUTERS
·
Dec 03

PolyPid Announces Positive FDA Pre-Nda Meeting Minutes for D-Plex₁₀₀ Supporting Nda Submission

THOMSON REUTERS
·
Dec 03

PolyPid Expands Share Offering to Strengthen Financial Position

TIPRANKS
·
Nov 27

PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025

GlobeNewswire
·
Nov 25

PolyPid Is Maintained at Buy by Roth Capital

Dow Jones
·
Nov 14

Roth MKM Remains a Buy on PolyPid (PYPD)

TIPRANKS
·
Nov 13

PolyPid price target lowered to $9 from $10 at Roth Capital

TIPRANKS
·
Nov 13

PolyPid’s Promising Future: Buy Rating Backed by D-PLEX100 Progress and Expanding Drug Delivery Pipeline

TIPRANKS
·
Nov 13

Biopharma firm PolyPid's Q3 net loss narrows to $7.5 mln

Reuters
·
Nov 12

PolyPid reports Q3 EPS (37c), consensus (52c)

TIPRANKS
·
Nov 12

PolyPid Q3 Cash & Equivalents $18.8M

Benzinga
·
Nov 12

PolyPid Q3 EPS $(0.37) Beats $(0.44) Estimate

Benzinga
·
Nov 12

BRIEF-PolyPid Q3 Net Income USD 7.451 Million

Reuters
·
Nov 12

PolyPid Ltd - Cash Balance Expected to Fund Operations Into 2026

THOMSON REUTERS
·
Nov 12

PolyPid Provides Corporate Update and Reports Third Quarter 2025 Financial Results

GlobeNewswire
·
Nov 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 12

PolyPid's D-PLEX₁₀₀ Wins BioTech Breakthrough Award for "Therapeutics Solution of the Year"

GlobeNewswire
·
Nov 06

PolyPid to Report Third Quarter 2025 Financial Results and Operational Highlights on November 12, 2025

GlobeNewswire
·
Oct 29